Cargando…
2801. Antimicrobial Spectrum of Plazomicin and Other Aminoglycosides against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales When Applying New Breakpoints
BACKGROUND: In March 2023, the Clinical and Laboratory Standards Institute (CLSI) lowered the Enterobacterales susceptible (S)/resistant breakpoints for amikacin from ≤16/≥64 mg/L to ≤4/≥16 mg/L and gentamicin and tobramycin from ≤4/≥16 mg/L to ≤2/≥8 mg/L. As aminoglycosides are frequently used to t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677846/ http://dx.doi.org/10.1093/ofid/ofad500.2412 |